Skip to main content

Articles

PSA Level at Age 60 Predicts Risk of Prostate Cancer Death 25 Years Later
TOP - Daily
A man’s level of prostate specific antigen (PSA) at age 60 predicts his lifetime risk of metastasis and death from prostate cancer, a study of Swedish men indicates.
 
The findings, published online September 14 in BMJ, could be useful in determining which men should be screened for prostate cancer after the age of 60 and which may not benefit substantially from continued screening.
 
Read More ›
Low-dose Aspirin Cuts Colorectal Cancer Risk
TOP - Daily
In a case-control study, regular use of 75 mg/day of aspirin— lower than the standard 81-mg dose of baby aspirin—significantly reduced the risk of developing colorectal cancer (CRC). The effect was evident after 1 year and increased with longer use.
 
The findings of this large population-based study are applicable to the general population, not just high-risk patients, according to the authors.
 
Read More ›
Albert Einstein Cancer Center Joins the NCCCP
August 2010 Vol 3, No 5

This past April, Albert Einstein Cancer Center was selected to join the National Cancer Institute (NCI) Community Cancer Centers Program (NCCCP), which, in the words of William J. Tester, MD, FACP, medical director of Einstein’s Cancer Center, offers “an opportunity to bring more resources to our patients.”

Read More ›
Novel Agents Improve Survival in Refractory Metastatic Breast Cancer
August 2010 Vol 3, No 5

CHICAGO—Several new agents elicited excitement for the treatment of women with advanced breast cancer, including a novel cytotoxic agent that is the first to improve survival as mono therapy in this challenging patient population.

In an international study, patients with metastatic breast cancer refractory to numerous treatments lived 2.5 months longer when treated with eribulin mesylate, a synthetic analog of the novel halichondrin B family, versus single agents alone.

Read More ›
Dying at Home Enhances Quality of Life
TOP - Daily
Patients with advanced cancer who die at home have greater quality of life (QOL) than patients who die in a hospital or intensive care unit. In addition, their caregivers experience less bereavement-related psychiatric illnesses, according to a study published online at the Journal of Clinical Oncology.
 
Read More ›
The Teenager with Cancer: Struggling to Be Heard and Understood
September 2010, Vol 3, No 6

BERLIN—The field of oncology has come a long way in improving communication between healthcare providers and their patients with cancer—that is, unless the patient happens to be an adolescent.

From diagnosis through treatment, profound deficits still remain in the care of this age group, according to several presentations at the Joint Congress of the European Cancer Organisation and European Society for Medical Oncology.

Read More ›
ADHD Drug Has Long-term Benefits for Childhood Cancer Survivors
TOP - Daily
Methylphenidate (MPH), a drug used to treat attention deficit hyperactivity disorder in healthy children also has long-term benefits for childhood cancer survivors, a new study indicates.
 
After 12 months of treatment with MPH, children showed significant improvements on measures of attention, social skills, and behavior compared with a control group of children who did not receive MPH.
 
Read More ›
Family Caregivers of Cancer Patients Benefit from Caregiver-targeted Interventions
September 2010, Vol 3, No 6
Interventions targeted to family caregivers of patients with cancer have modest but significant positive effects on coping ability and other caregiver outcomes, a new meta-analysis indicates.
 
Read More ›
Risk Model to Predict VTE in Cancer Patients
TOP - Daily
Adding two new biomarkers to a risk-prediction model allows enhanced identification of cancer patients at high or low risk of venous thromboembolism (VTE), according to a recent study published in Blood.
 
Read More ›

Page 277 of 289